Compounds > celecoxib
Page last updated: 2024-10-24

celecoxib and Intestinal Diseases

celecoxib has been researched along with Intestinal Diseases in 7 studies

Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nuki, Y2
Umeno, J1
Washio, E2
Maehata, Y2
Hirano, A1
Miyazaki, M2
Kobayashi, H2
Kitazono, T2
Matsumoto, T2
Esaki, M3
Srinivas, NR1
Fujimori, S1
Fukunaga, K1
Takahashi, A1
Mushiroda, T1
Kubo, M1
Hanada, R1
Hayashida, M1
Sakurai, T1
Iwakiri, K1
Sakamoto, C1
Ishikawa, H1
Scheiman, JM1
Goldstein, JL1
Eisen, GM1
Lewis, B1
Gralnek, IM1
Aisenberg, J1
Bhadra, P1
Berger, MF1

Trials

4 trials available for celecoxib and Intestinal Diseases

ArticleYear
The influence of CYP2C19 polymorphisms on exacerbating effect of rabeprazole in celecoxib-induced small bowel injury.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:3

    Topics: Adult; Capsule Endoscopy; Celecoxib; Cytochrome P-450 CYP2C19; Double-Blind Method; Female; Genotype

2017
Proton Pump Inhibitors Increase Incidence of Nonsteroidal Anti-Inflammatory Drug-Induced Small Bowel Injury: A Randomized, Placebo-Controlled Trial.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Celecoxib; Double-Blind Method; F

2016
What are the effects of cyclooxygenase-2-specific inhibitors on the small bowel?
    Nature clinical practice. Gastroenterology & hepatology, 2005, Volume: 2, Issue:5

    Topics: Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Therapy, Combination; Follow-

2005
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy.
    Alimentary pharmacology & therapeutics, 2007, May-15, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Celecoxib; Drug

2007

Other Studies

3 other studies available for celecoxib and Intestinal Diseases

ArticleYear
Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury-authors' reply.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:7

    Topics: Celecoxib; Cytochrome P-450 CYP2C19; Humans; Intestinal Diseases; Intestine, Small; Rabeprazole

2017
Letter: CYP2C19 polymorphisms and exacerbation of rabeprazole's effects on celecoxib-induced small bowel injury.
    Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:7

    Topics: Aryl Hydrocarbon Hydroxylases; Celecoxib; Cytochrome P-450 CYP2C19; Humans; Intestinal Diseases; Int

2017
Bactericidal/Permeability-Increasing Fold-Containing Family B Member 4 May Be Associated with NSAID-Induced Enteropathy.
    Digestive diseases and sciences, 2019, Volume: 64, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Celecoxib; Female; Genome-Wide As

2019